Revolutionary diagnostic cancer test
Diether Lambrechts and his team at VIB-KU Leuven study genetic mutations in solid tumors, including microsatellite instabilities (MSI). Through their research, they have identified seven new biomarkers for MSI that can be used for automated MSI testing. Biocartis has obtained the exclusive license for these biomarkers and has introduced the IdyllaTM MSI Assay. This technology assists doctors in making treatment decisions for patients with colorectal cancer.